Skip to Content
MilliporeSigma
HomeServicesBioReliance® Contract Testing ServicesFinal Product Release Testing

Final Product Release Testing

Final Product Release Testing

To help you demonstrate compliance with regulatory guidelines prior to releasing your biologics into global pharmaceutical markets, we offer a wide range of GMP assays and testing services for your final product packages.   

Our experts can provide final product testing services for:

For more about final product testing of your biologic, use our reply form to get in touch today.

Contact us today to learn more or request a quote

Related Product Resources

Flyer: Comprehensive Lot Release Testing
Poster: A Viral Safety Strategy for Gene Therapy Viral Vectors

Related Applications
Monoclonal Antibody Manufacturing
Monoclonal antibody manufacturing is a highly templated approach used to produce mAb-based immunotherapies. Robust, scalable process solutions are required at every step to ensure high therapeutic concentration and process safety, while meeting speed-to-market and cost containment concerns.
Gene Therapy Manufacturing
Gene therapy innovation requires integrated manufacturing, testing, safety, and compliance expertise from experienced partners.
Cell Therapy Manufacturing
Introducing a new cell therapy demands optimal performance in upstream and downstream processing, process development, testing, and manufacturing. World-class products and partners are critical to success, speeding advancement of therapeutics that are effective, safe, and affordable.
Vaccine Manufacturing
From early phase development, through downstream purification to large scale vaccine production: learn more about vaccine process development and application expertise.
Related Services
Raw Material Testing
Our raw material testing helps ensure the quality and purity of materials used in biologics production.
Bulk Harvest Release Testing
cGMP-compliant bulk harvest release testing services safeguard therapeutic biologics from first-in-human trials to global distribution.
Sign In To Continue

To continue reading please sign in or create an account.

Don't Have An Account?